Feedback / Questions
faridoxorubicin (AVA6000) - Avacta
AVA-6103 - Avacta
https://www.manilatimes.net/2026/09/16/tmt-newswire/globenewswire/avacta-achieves-clinical-proof-of-mechanism-for-the-next-generation-of-precision-medicines-with-ava6103-fap-exd-in-the-phase-1-focus-01-trial/2426803/amp
Sep 16, 2026
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Next